Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maximilian Tak-Sui Li"'
Autor:
Kin-Wai Tam, Cheuk-Yin Wong, Kenneth Lap-Kei Wu, Guy Lam, Xiaotong Liang, Wai-Ting Wong, Maximilian Tak-Sui Li, Wing-Yui Liu, Sa Cai, Graham Ka-Hon Shea, Daisy Kwok-Yan Shum, Ying-Shing Chan
Publikováno v:
Cells, Vol 12, Iss 11, p 1479 (2023)
The in vitro derivation of Schwann cells from human bone marrow stromal cells (hBMSCs) opens avenues for autologous transplantation to achieve remyelination therapy for post-traumatic neural regeneration. Towards this end, we exploited human induced
Externí odkaz:
https://doaj.org/article/000f0252e88541eea75e4619fd6c2a5b
Autor:
Yat-Ping Tsui, Guy Lam, Kenneth Lap-Kei Wu, Maximilian Tak-Sui Li, Kin-Wai Tam, Daisy Kwok-Yan Shum, Ying-Shing Chan
Publikováno v:
Cells, Vol 10, Iss 8, p 2166 (2021)
Transplantation of oligodendrocyte precursors (OPs) is potentially therapeutic for myelin disorders but a safe and accessible cell source remains to be identified. Here we report a two-step protocol for derivation of highly enriched populations of OP
Externí odkaz:
https://doaj.org/article/0281f6d650d84877874b6c905c102304
Autor:
Daisy K.Y. Shum, Anthony Kin‐Wai Tam, YS Chan, Alex Tsui, Maximilian Tak-Sui Li, Graham Ka-Hon Shea, Evelyn Wing-Yin Tai, Alan Kwan-Long Mung, Katherine Ho‐Yan Leung
Publikováno v:
European Journal of Neuroscience. 52:3306-3321
The phenotypic instability of adult tissue-derived Schwann cell-like cells (SCLCs) as revealed upon withdrawal of glia-inducing culture supplements limits their clinical utility for cell therapy and disease modelling. We previously overcame this limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c2d1d11c149702fdf7dd4ea8eb4671
https://doi.org/10.1111/ejn.14837
https://doi.org/10.1111/ejn.14837
Autor:
YS Chan, Guy Lam, Maximilian Tak-Sui Li, Daisy K.Y. Shum, Kenneth Lap-Kei Wu, KW Tam, Yat-Ping Tsui
Publikováno v:
Cells
Cells, Vol 10, Iss 2166, p 2166 (2021)
Volume 10
Issue 8
Cells, Vol 10, Iss 2166, p 2166 (2021)
Volume 10
Issue 8
Transplantation of oligodendrocyte precursors (OPs) is potentially therapeutic for myelin disorders but a safe and accessible cell source remains to be identified. Here we report a two-step protocol for derivation of highly enriched populations of OP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826ba506d77267c409866799671e3a24
http://europepmc.org/articles/PMC8391516
http://europepmc.org/articles/PMC8391516